Lineage Cell Therapeutics LCTX
NYSE LCTX
$0.95 -0.02 (-1.69%)
As of: Sep 29, 2026 · 3:59 PM EDT

Lineage Cell Therapeutics (LCTX) Enterprise Value (2010 - 2026)

Updated

Lineage Cell Therapeutics (LCTX) reported Enterprise Value of $279.36 million for Q2 2026, up 70.1% from $164.24 million a year earlier but down 17.7% from the prior quarter.

Analysis

Lineage Cell Therapeutics (LCTX) Enterprise Value (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Lineage Cell Therapeutics' Enterprise Value came in at $129.71 million, up 262.1% year-over-year; for FY2025, it was $349.03 million, up 471.9% from FY2024.

  • Enterprise Value has a five-year compound annual growth rate of 9.6% (FY2020 to FY2025).
  • By year, Enterprise Value came in at $61.03 million in FY2024 (-60.3%), $153.85 million in FY2023 (+10.1%), $139.73 million in FY2022 (-60.7%) and $355.54 million in FY2021 (+60.9%).
  • Five-year quarterly Enterprise Value spans a low of $53.48 million in Q1 2025 and a high of $358.3 million in Q3 2021.
  • Year over year, Enterprise Value has now increased in each of the last five quarters, with growth averaging 135.7% over the last eight quarters.
  • The high point for year-over-year Enterprise Value in five years was Q1 2026 (growth of 534.5%); the low point was Q1 2025 (a decline of 77.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $339.33 million (Q1 2026), $349.03 million (Q4 2025) and $347.52 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Lineage Cell Therapeutics 245.32 Mn 43.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 279.36 Mn
Mar 31, 2026 339.33 Mn
Dec 31, 2025 349.03 Mn
Sep 30, 2025 347.52 Mn
Jun 30, 2025 164.24 Mn
Mar 31, 2025 53.48 Mn
Dec 31, 2024 61.03 Mn
Sep 30, 2024 137.74 Mn
Jun 30, 2024 148.90 Mn
Mar 31, 2024 234.32 Mn
Dec 31, 2023 153.85 Mn
Sep 30, 2023 163.65 Mn
Jun 30, 2023 198.63 Mn
Mar 31, 2023 207.01 Mn
Dec 31, 2022 139.73 Mn
Sep 30, 2022 124.22 Mn
Jun 30, 2022 194.82 Mn
Mar 31, 2022 180.11 Mn
Dec 31, 2021 355.54 Mn
Sep 30, 2021 358.30 Mn
API Access

Lineage Cell Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=LCTX&period=max&api_key=YOUR_API_KEY